Mechanism of epigenetic-driven inactivation of tumor suppressor SIGIRR
2015/19/B/NZ6/01578
Keywords
Descriptors
- NZ6_2: Immunologia kliniczna
- NZ5_3: Patogeneza chorób człowieka
- NZ2_2: Genomika, transkryptomika i epigenomika
Panel
NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
OPUS 10 – announced on 2015-09-15
- Amount awarded
- 2 000 000 PLN
- Project start date
- 2016-10-03
- Project end date
- 2022-04-02
- Project duration
- 66 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Komputer stacjonarny. Cost: 6 000 PLN
- Pompa perystaltyczna. Cost: 6 361 PLN
- Seahorse XFp Extracellular Flux Analyzer. Cost: 260 000 PLN
- licznik komórek. Cost: 19 998 PLN
- zestaw do elektroforezy. Cost: 9 243 PLN
Information in the final report
Publication in academic press/journals (3)
-
Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis
- Authors:
- Bulek K, Zhao J, Liao Y, Rana N, Corridoni D, Antanaviciute A, Chen X, Wang H, Qian W, Miller-Little WA, Swaidani S, Tang F, Willard BB, McCrae K, Kang Z, Dubyak GR, Cominelli F, Simmons A, Pizarro TT, Li X.
- Academic press:
- The Journal of Clinical Investigation (year: 2020, volume: 130(8), pages: 4218–4234), Publisher: The American Society for Clinical Investigation
- Status:
- Published
- DOI:
- 10.1172/JCI138103 – link to the publication
-
The Ras GTPase-activating-like protein IQGAP1 bridges Gasdermin D to the ESCRT system to promote IL-1β release via exosomes
- Authors:
- Liao Y*, Chen X, Miller-Little W, Wang H, Willard B, Bulek K*, Zhao J*, Li X*, *corresponding author
- Academic press:
- The EMBO Journal (year: 2022, volume: 46340, pages: e110780), Publisher: EMBO press
- Status:
- Published
- DOI:
- 10.15252/embj.2022110780 – link to the publication
-
Dominant-Negative Form of SIGIRR: SIGIRRΔE8 Promotes Tumor Growth Through Regulation of Metabolic Pathways
- Authors:
- Bodaszewska-Lubas M, Liao Y, Zegar A, Szelest O, Dobrucki J, Bulek K*, *corresponding author
- Academic press:
- Journal of Interferon & Cytokine Research (year: 2022, volume: 42(9), pages: 482-492), Publisher: Mary Ann Liebert, Inc
- Status:
- Published
- DOI:
- 10.1089/jir.2022.0095 – link to the publication